2Taniguehi Y, Hayashi T, Tsumura K, et al . Serum uric acid and the riskfor hypertension and type diabetes in Japanese men : The osaka health survey[J]. J Hypertens, 2001 , 19 : 1209.
3Jonson RJ. Uric acid and die-insights into the epidemic of cardiovascular disease[ J ].N Engl J Med,2004,350:1071.
4Mazali M, Hughes J, Kim YG, et al . Elevated uric aid increases blood pressure in the rat by a novel crystal2independent mechanism [J].Hypertension, 2001,38:1101.
5Sever PS,Dahif B, Pouher NR, et al . Preventi on of coronary and stoke events with at -orvastatin in hypertensive patients who have average or lower - than 3/average cholesterol concentrations, in the angio-scandinavian cardiac qutcomes. Trial-lipid losering Am (ASCOT - LLA) : a multicentre randi omized controlled trial[ J ]. Lancet, 2003, 361:1149.
9Gross CM, Gerbaaulet S, Quensel C, et al. Angiotensin II type I receptor expression in human coronary arteries with inable degrees of a the rescle ross[J]. Basic Resparation Cadial, 2002, 97 : 327.
9[1]Balt J C,Mathy M J,Nap A.Prejunctional and postjunctional inhibitory actions of Eprosartan and Candesartan in the isolated rabbit mesenteric artery.2002;40(1):50
10[2]Milljg M,Mdac B,et al.Activation of the cardiac angotensin converting enzyme converting after myocardialinfarction and itsroleinven mcualrre modeling.1997;69:101-113
